Rosenblit M D
Rev Bras Pesqui Med Biol. 1976 Jan-Feb;9(1):45-53.
After infusion of 51Cr--labeled isologous platelets into one patient with no hematological disease and into four patients with thrombocytopenia, radioactivity was measured from 1 to 8 days. Normal platelets survival was determined as 7 to 8 days in the first patient, whereas the thrombocytopenic patients showed a reduced survival, between 1 to 2 days. The percentage of maximum recovery of transfused platelets was severely reduced in those patients with thrombocytopenia, ranging from 13 to 18%, as compared with the normal 50% found in the first patient. Surface scanning of the spleen, liver and precordium, served as an index for selective platelet sequestration, and it was positive only in case of chronic idiopathic thrombocytopenic purpura (ITP). Despite the low incorporation to the platelets, 51Cr seems to be a suitable label as well as the method described. The pathological aspects of the platelets survival are discussed.
将51Cr标记的同源血小板输注到1例无血液系统疾病的患者和4例血小板减少症患者体内后,在1至8天内测量放射性。确定第一例患者的正常血小板生存期为7至8天,而血小板减少症患者的生存期缩短,为1至2天。与第一例患者正常的50%相比,血小板减少症患者输注血小板的最大恢复百分比严重降低,范围为13%至18%。对脾脏、肝脏和心前区进行表面扫描,作为血小板选择性滞留的指标,仅在慢性特发性血小板减少性紫癜(ITP)患者中呈阳性。尽管51Cr与血小板的结合率较低,但它似乎是一种合适的标记物,所描述的方法也是如此。文中讨论了血小板生存期的病理情况。